129311-55-3
129311-55-3 structure
- Name: Ganirelix Acetate
- Chemical Name: Ganirelix acetate
- CAS Number: 129311-55-3
- Molecular Formula: C84H121ClN18O17
- Molecular Weight: 1690.423
- Catalog: Signaling Pathways GPCR/G Protein GNRH Receptor
- Create Date: 2018-07-18 19:41:50
- Modify Date: 2024-01-06 19:04:48
-
Ganirelix acetate (Ganirest) is an injectable competitive gonadotropin-releasing hormone (GnRH) antagonist. Ganirelix acetate directly competes against the endogenous molecule for receptor binding, and causes a rapid reduction in estradiol levels. Ganirelix acetate can be used for researching ovarian hyperstimulation syndrome (OHSS)[1].
| Name | Ganirelix acetate |
|---|---|
| Synonyms |
56U7906FQW
D-Alaninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-L-tyrosyl-N6-[bis(ethylamino)methylene]-D-lysyl-L-leucyl-N6-[bis(ethylamino)methylene]- ;L-lysyl-L-prolyl-, acetate (1:2) Ganirelix acetate UNII:56U7906FQW N-Acetyl-3-(2-naphthyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-L-tyrosyl-N6-[bis(ethylamino)methylene]-D-lysyl-L-leucyl-N6-[bis(ethylamino)methylene]-L-lysyl-L-prolyl-D- ;alaninamide acetate (1:2) |
| Description | Ganirelix acetate (Ganirest) is an injectable competitive gonadotropin-releasing hormone (GnRH) antagonist. Ganirelix acetate directly competes against the endogenous molecule for receptor binding, and causes a rapid reduction in estradiol levels. Ganirelix acetate can be used for researching ovarian hyperstimulation syndrome (OHSS)[1]. |
|---|---|
| Related Catalog | |
| Target |
GnRH[1] |
| References |
| Molecular Formula | C84H121ClN18O17 |
|---|---|
| Molecular Weight | 1690.423 |
| Exact Mass | 1688.884521 |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| RIDADR | NONH for all modes of transport |